Melatonin-controlled release - Neurim pharmaceuticals: Circadin®, melatonin-prolonged release, melatonin-sustained release

Drugs in R and D

Volumn 4, Issue 2, 2003, Pages 131-132

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MELATONIN; NEUROLEPTIC AGENT; PLACEBO;

ARTICLE; CANADA; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DRUG EFFICACY; DRUG INDUSTRY; ELDERLY CARE; EUROPE; HUMAN; INSOMNIA; ISRAEL; LICENCE; PATENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SLEEP; SUSTAINED RELEASE FORMULATION; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

EID: 0041355255     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200304020-00011     Document Type: Article

References (2)

1. Garfinkel D, et al. Improvement in sleep quality in elderly people by controlled-release melatonin. Lancet 348: 541-544, 1995
2. Shamir E, Barak Y, Shalman I, Laudon M, Zisapel N, et al. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Archives of General Psychiatry 58: 1049-1052, Nov 2001